Abstract     Description     Claims  

WO2006080463A   [0005] 
WO2013015661A   [0005] 
WO2009018389A   [0005] 
WO2005097803A   [0005] 
WO2016157052A   [0005] 
WO2009036059A   [0148] 
WO2012119265A   [0157]  [0163] 
WO2013120229A   [0157]  [0163] 
WO2013128037A   [0157]  [0163] 

Nature Reviews Drug Discovery   [0006] 
BMC Cancer   [0006] 
Protective Groups in Organic Synthesis   [0147]  [0150]  [0152]  [0154]  [0156]  [0160]  [0162]  [0165]  [0176]  [0178]  [0180]  [0182]  [0184]  [0186]  [0188]  [0190] 
J. Am. Chem. Soc.   [0168] 
Tetrahedron   [0168] 
J. Am. Chem. Soc.   [0171] 
J. Org. Chem.   [0171] 
J. Med. Chem.   [0171] 
J. Am. Chem. Soc.   [0174] 
J. Org. Chem.   [0174] 
Tetrahedron   [0174] 
J. Org. Chem.   [0174] 
J. Org. Chem.   [0174] 
Bioconjugate Chem.   [0181] 
Mol. Pharmaceutics   [0181] 
Protective Groups in Organic Synthesis   [0192] 
Jikken Kagaku Koza (The Chemical Society   [0197] 
Comprehensive Organic Transformations   [0198]